You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 1, January 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL NOTES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (43)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Liver Allograft

Its Use in Chronic Active Hepatitis With Macronodular Cirrhosis, Hepatitis B Surface Antigen

Jacques L. Corman, MD; Charles W. Putnam, MD; Shunzaburo Iwatsuki, MD; Allan G. Redeker, MD; K. A. Porter, MD; Robert L. Peters, MD; Gerhard Schröter, MD; Thomas E. Starzl, MD, PhD

Arch Surg. 1979;114(1):75-78.


Abstract

• A patient suffering from chronic active hepatitis with macronodular cirrhosis, positive for hepatitis B surface antigen (HBsAg), was treated with an orthotopic liver allograft. The HBs antigenemia, as measured with several precipitation tests and by complement fixation, became negative after transplantation and remained so for about 21/2 months. During the interval, very low titers of the antigen were detectable by radioimmunoassay. At about three months after transplantation, she had an attack of acute hepatitis, at which time HBsAg became detectable by all tests. She recovered, but progressive liver disease developed during the remaining 11/2 years of her life. She died of disseminated nocardiosis and candidiasis with deteriorating hepatic function. The homograft at autopsy showed no evidence of rejection, but was the site of chronic active liver disease, although of a different pathologic pattern than that affecting her native liver. The differences in histology may reflect the influence of chronic immunosuppression on the features of chronic active hepatitis.

(Arch Surg 114:75-78, 1979)



Author Affiliations

From the Department of Surgery (Drs Corman, Putnam, Iwatsuki, Schröter, and Starzl), University of Colorado Medical Center, Denver; the Department of Medicine, University of Southern California, Rancho Los Amigos Hospital, Downey (Dr Redeker); the Department of Pathology, St Mary's Hospital Medical School, London (Prof Porter); and Department of Pathology, John Wesley Hospital, Los Angeles (Dr Peters). Dr Corman is now with L'Universite de Montreal, Hopital Notre-Dame; Dr Putnam the Department of Surgery, Tucson (Ariz) Veterans Administration Hospital; and Dr Iwatsuki the Department of Surgery, Loyola University Medical Center, Maywood, Ill.


Footnotes

Accepted for publication May 16, 1978.

Reprint requests to Department of Surgery (Box C-305), University of Colorado Medical Center, 4200 E Ninth Ave, Denver, CO 80262 (Dr Starzl).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.